Investing.com - Itamar Medical reported on Thursday third quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Itamar Medical announced earnings per share of $-0.49 on revenue of $13.57M. Analysts polled by Investing.com anticipated EPS of $-0.17 on revenue of $13.41M.
Itamar Medical shares are up 54.08% from the beginning of the year and are trading at $30.60 , down-from-52-week-high.They are outperforming the Nasdaq which is up 23.54% from the start of the year.
Itamar Medical follows other major Healthcare sector earnings this month
Itamar Medical's report follows an earnings beat by Pfizer on November 2, who reported EPS of $1.34 on revenue of $24.09B, compared to forecasts EPS of $1.08 on revenue of $22.58B.
Novo Nordisk ADR had beat expectations on November 3 with third quarter EPS of $0.8209 on revenue of $5.55B, compared to forecast for EPS of $0.7768 on revenue of $5.39B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar